This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zindy, F.
Right arrow Articles by Roussel, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zindy, F.
Right arrow Articles by Roussel, M. F.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2000, p. 372-378, Vol. 20, No. 1
0270-7306/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

INK4d-Deficient Mice Are Fertile Despite Testicular Atrophy

Frederique Zindy,1 Jan van Deursen,2 Gerard Grosveld,2 Charles J. Sherr,1,3 and Martine F. Roussel1,*

Departments of Tumor Cell Biology1 and Genetics2 and Howard Hughes Medical Institute,3 St. Jude Children's Research Hospital, Memphis, Tennessee 38105

Received 26 August 1999/Returned for modification 21 September 1999/Accepted 22 September 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The INK4 family of cyclin-dependent kinase (CDK) inhibitors includes four 15- to 19-kDa polypeptides (p16INK4a, p15INK4b, p18INK4c, and p19INK4d) that bind to CDK4 and CDK6. By disrupting cyclin D-dependent holoenzymes, INK4 proteins prevent phosphorylation of the retinoblastoma protein and block entry into the DNA-synthetic phase of the cell division cycle. The founding family member, p16INK4a, is a potent tumor suppressor in humans, whereas involvement, if any, of other INK4 proteins in tumor surveillance is less well documented. INK4c and INK4d are expressed during mouse embryogenesis in stereotypic tissue-specific patterns and are also detected, together with INK4b, in tissues of young mice. INK4a is expressed neither before birth nor at readily appreciable levels in young animals, but its increased expression later in life suggests that it plays some checkpoint function in response to cell stress, genotoxic damage, or aging per se. We used targeted gene disruption to generate mice lacking INK4d. These animals developed into adulthood, had a normal life span, and did not spontaneously develop tumors. Tumors did not arise at increased frequency in animals neonatally exposed to ionizing radiation or the carcinogen dimethylbenzanthrene. Mouse embryo fibroblasts, bone marrow-derived macrophages, and lymphoid T and B cells isolated from these animals proliferated normally and displayed typical lineage-specific differentiation markers. Males exhibited marked testicular atrophy associated with increased apoptosis of germ cells, although they remained fertile. The absence of tumors in INK4d-deficient animals demonstrates that, unlike INK4a, INK4d is not a tumor suppressor but is instead involved in spermatogenesis.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell proliferation is positively regulated by cyclin-dependent kinases (CDKs), and in normal cells, progression through the G1 phase of the cell cycle depends upon the activities of cyclin D-dependent CDK4 or CDK6, and later, on cyclin E- and A-dependent CDK2 (reviewed in reference 45). These holoenzymes cooperate to phosphorylate the retinoblastoma protein (Rb), canceling its growth-suppressive function and initiating an E2F-dependent transcriptional program that is necessary for entry into the DNA synthetic (S) phase of the cell cycle (reviewed in references 7 and 49). In addition, cyclin E-CDK2 complexes phosphorylate additional substrates whose modifications are required for G1 exit and initiation of DNA replication (reviewed in reference 39).

The activities of the G1 CDKs can be blocked by CDK inhibitors (CKIs) that, in mammalian cells, fall into one of two distinct families (reviewed in references 44 and 46). The INK4 class (Inhibitors of CDK4) consists of four members (p16INK4a, p15INK4b, p18INK4c, and p19INK4d) that exclusively bind to and inhibit the cyclin D-dependent catalytic subunits CDK4 and CDK6. By contrast, the Cip/Kip family includes three members (p21CIP1, p27KIP1, and p57KIP2) that bind to both cyclins and CDKs to preferentially inhibit cyclin E- and A-dependent CDK2.

CKIs act cooperatively during the G1 phase of the cell division cycle. As cells enter the cycle from quiescence and progress through G1 phase, Cip/Kip proteins initially act as positive regulators of the cyclin D-dependent kinases, aiding in their mitogen-dependent assembly, stabilization, and nuclear import (5, 21) and remaining associated with cyclin D-CDK complexes without inhibiting their activities (2, 21, 47, 51). (In this context, the term CDK inhibitor is a misnomer.) Apart from assembling into active complexes with D-type cyclins and Cip/Kip subunits, CDK4 and CDK6 can alternatively enter into inactive binary complexes with INK4 proteins, which may normally serve as a sink for any unutilized or improperly folded CDK subunits. The balance between formation of these different CDK4- and CDK6-containing complexes is likely set by the accumulation of cyclin D regulatory subunits in response to mitogenic stimulation (driving assembly of active complexes containing Cip/Kip proteins) and, conversely, by certain antiproliferative signals that can act to increase the relative concentrations of INK4 proteins (reviewed in reference 44). Kinetic studies performed both in vitro and in vivo have indicated that the association of INK4 proteins with CDK4 prevents Cip/Kip binding, and vice versa (36), consistent with more recently obtained structural data (3, 41) (reviewed in reference 32). During G1 phase progression, the sequestration into higher-order cyclin D-CDK complexes of Cip/Kip proteins lowers their effective inhibitory threshold, thereby enabling cyclin E- and A-dependent CDK2 to become active as cells approach the G1-to-S-phase transition. On the other hand, by binding to CDK4 or CDK6, induced INK4 proteins disrupt cyclin D-dependent kinases, canceling their activities and liberating the latent pool of Cip/Kip proteins, which can then act to inhibit CDK2. Therefore, the enforced expression of INK4 proteins in mammalian cells inhibits the activity of all G1-phase CDKs and induces growth arrest by preventing entry into the S phase of the cell cycle (1, 16, 23-25, 31, 36, 37).

Although they appear to be structurally redundant and equally potent as inhibitors, the INK4 family members are differentially expressed during mouse development (54). INK4c and INK4d are widely expressed during mouse embryogenesis while INK4a and INK4b expression are undetectable before birth. By 4 weeks of age, p15INK4b, p18INK4c, and p19INK4d can be detected in many mouse tissues, but p16INK4a protein expression is initially restricted to the lung and spleen of somewhat older mice, with increasing and more widespread expression becoming manifest as the animals age. In humans, p16INK4a, the founding member of the family (42), functions as a potent tumor suppressor, whereas the roles of other INK4 family members, if any, in tumorigenesis remain largely anecdotal (40). Mice deficient in INK4a develop normally and are highly cancer prone (43). However, these animals also lack the p19ARF product of the INK4a alternative reading frame (33), whose disruption (with retention and expression of p16INK4a-coding sequences) reproduces the same tumor-prone phenotype (17). Hence, the formal demonstration that p16INK4a acts as a tumor suppressor in mice awaits the production of animals that lack INK4a but retain alternative reading frame function.

Mice deficient in INK4c develop gigantism and widespread organomegaly; middle lobe pituitary tumors later in life (9); and, less commonly, seminomas, adrenal pheochromocytoma, and renal glomerulopathies (M. Barbacid, personal communication). These animals display increased numbers of lymphoid B and T cells, with the cells undergoing accelerated proliferation upon mitogenic stimulation (9). Disruption of INK4b leads to extramedullary hematopoiesis and to formation of secondary follicles in lymph nodes as well as to tumors of various tissues in a small percentage of animals. When crossed onto an INK4c-null background, INK4b loss did not exacerbate the abnormalities observed in INK4c-deficient mice (M. Barbacid, personal communication). This may seem surprising in retrospect, given the fact that p15INK4b is strongly induced by transforming growth factor beta  (11, 37), while p18INK4c is induced by interleukin-6 (IL-6) (26).

Here, we show that deletion of INK4d in the mouse, like that of other INK4 members, does not affect mouse development. INK4d-deficient mice showed no gross anomalies, had a normal life span, and did not develop tumors, and primary cells of different lineages isolated from these animals had unremarkable proliferative properties. Males displayed marked testicular atrophy associated with increased apoptosis, without apparently compromising their fertility.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Targeting of INK4d. The genomic DNA encoding the INK4d gene was cloned from a bacteriophage library prepared from 129/sv embryonic stem (ES) cells using a full-length murine INK4d cDNA probe (12). A 14-kb EcoRV-HindIII fragment containing the two coding exons was isolated. A cassette containing the lacZ gene (beta -geo) fused to the neomycin resistance gene was inserted in the second coding exon at a unique SpeI site, and the targeting vector was electroporated into E14R3M4 ES cells. Correct homologous recombination occurred at 7.6% frequency as determined by Southern blotting analysis of ES cell DNA. DNA was digested with BglII or HindIII, was separated on an agarose gel, was transferred to nitrocellulose, and was hybridized with a 3' (probe B) or a 5' (probe A) probe (Fig. 1). Probe B detects a 9.5-kb fragment in the wild-type allele and a 14-kb fragment in the mutant allele. Probe A detects a 14-kb fragment from the wild-type allele and an 11-kb fragment in the DNA of mutant mice. Mice were routinely genotyped by isolating tail DNA and digesting it with BglII followed by Southern blotting analysis using probe B. 


View larger version (12K):
[in this window]
[in a new window]
  		FIG. 1.   Mouse INK4d locus, targeting vector, and targeted allele. The upper line shows a map of the INK4d locus with exons 1 and 2 defined by filled bars and various restriction sites indicated. R1, EcoRI; HIII, HindIII; Bg, BglII; RV, EcoRV. The unique SpeI site in exon 2 is circled. A beta -geo gene flanked by an internal ribosome entry site (IRES) was inserted into the SpeI site in exon 2 to generate the targeting cassete. The map of the recombined locus is shown by the lower line. Probes A and B corresponding to restriction fragments flanking INK4d coding sequences (top) are predicted to differentially hybridize to the HindIII and BglII fragments defined at the top (wild-type allele) and at the bottom (mutant allele).

Histology, in situ hybridization, protein analysis, and TUNEL assays. Male mice were overdosed with intraperitoneal injections of ketamine and rompun and perfused intracardially with a fixative containing 4% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.6, for 20 min. Isolated testes were postfixed in the same solution for 4 h at 4°C and were transferred into 25% sucrose in 0.1 M sodium phosphate buffer, pH 7.6, at 4°C for an additional 24 h. Sections of 12-µm thickness were cut with a cryostat, were mounted on Fisher brand Super-frost-plus slides, and were stored at -20°C. For routine histology, sections were stained with 0.05% toluidine blue in a solution containing Walpole's acetic acid and sodium acetate buffer, pH 4.4. In situ hybridization (55) and immunoblotting analysis (54) were performed as previously described. Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays were performed by using the ApopTag detection kit (Oncor, Gaithersburg, Md.), essentially following manufacturer's instructions with minor modifications depending upon the specimen preparation. In brief, sections were postfixed for 15 min in 4% paraformaldehyde, were washed twice with phosphate-buffered saline (PBS), and were incubated in ethanol-acetic acid (2:1) for 5 min at -20°C. After two washes in PBS, sections were subjected to a proteinase K digestion (10 µg/ml in 10 mM Tris HCl, pH 8.0, and 1 mM EDTA), were washed twice with PBS, and were counterstained with methyl green. beta -Galactosidase staining was performed as previously described (29). Tissues were counterstained with 1% neutral red in a solution containing Walpole's acetic acid and sodium acetate buffer.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Targeted disruption of INK4d in the mouse. We disrupted the mouse INK4d gene by homologous recombination in ES cells (Fig. 1). The p19INK4d protein is a 166-amino-acid polypeptide encoded by two exons: exon 1 (codons 1 to 47) and exon 2 (codons 48 to 166) (12). We inserted a beta -geo cassette containing LacZ fused to the neomycin resistance (neo) gene into the second exon of INK4d. Seven independent ES cell clones, screened for homologous recombination by Southern blotting analysis, were microinjected into blastocysts from C57BL/6 mice to generate chimeric animals. Two chimeric mice, derived from two independently targeted ES cell clones, transmitted the disrupted allele through the germ line after breeding with C57BL/6 mice. The phenotypes of both independently derived mouse strains, as described below, are identical.

Heterozygotes were mated to produce founder strains of all three genotypes, including INK4d wild-type mice (+/+), heterozygotes (+/-), and nullizygotes (-/-), each verified by Southern blotting analysis of tail DNA (Fig. 2A). We detected no expression of p19INK4d protein in testes (Fig. 2B) or other organs (see below) of INK4d-deficient animals, while the levels of p19INK4d protein in tissues of heterozygous animals were approximately half those detected in their wild-type littermates (Fig. 2B). In situ mRNA hybridization and immunostaining confirmed the absence of INK4d mRNA expression and demonstrated expression of beta -galactosidase in place of p19INK4d (see below). Furthermore, the loss of p19INK4d protein expression in various tissues from INK4d-deficient mice was not compensated by detectable increases in the expression of other INK4 proteins (Fig. 2C). As noted previously (54), p15INK4b, p18INK4c, and p19INK4d could be readily detected in different tissues of 2-month-old animals, whereas p16INK4a expression was conspicuously absent at this time. Pertinent to results that follow, p15INK4b, p18INK4c, and p19INK4d were each expressed in testes, although p19INK4d predominated.


View larger version (31K):
[in this window]
[in a new window]
  		FIG. 2.   INK4d genotype and expression. (A) Southern blotting analysis of tail DNA taken from littermates derived from interbred INK4d+/- hemizygotes. DNA was digested with BglII, was transferred to nitrocellulose, and was hybridized with probe B (Fig. 1, top). (B) p19INK4d protein expression in testes from mice of the indicated genotypes, as determined by sequential immunoprecipitation and immunoblotting. (C) INK4 protein expression in kidney, spleen, brain, and testis from 8-week-old wild-type (+/+) and INK4d-null (-/-) mice determined as for panel B. Mouse erythroleukemia (MEL) cells were used as a positive control for p16INK4a and p18INK4c expression.

Viability and phenotypic analysis of INK4d-deficient mice. Interbreeding of INK4d heterozygotes yielded offspring at a normal Mendelian ratio (25.5% +/+, 54.2% +/-, and 22.3% -/-; total of 238 mice) indicating that, in spite of the expression of INK4d during normal embryogenesis (54), its loss did not affect fetal development or survival. Apart from abnormalities in testicular size and male germ cell maturation (see below), no other overt developmental anomalies were observed in INK4d-deficient animals, which were fertile and had an otherwise uncomplicated and normal life span.

Given that human p16INK4a acts as a potent tumor suppressor (reviewed in reference 40) and that mice lacking p18INK4c develop middle lobe pituitary tumors (9) and, less often, seminomas and adrenal pheochromocytomas (M. Barbacid, personal communication), we explored the possibility that INK4d might play a role in tumor suppression. A cohort of 50 INK4d-deficient mice was observed for spontaneous tumor development for more than 2 years. Eight animals died of unknown causes in their second year of life at a frequency indistinguishable from that of their wild-type littermates (7 of 59), all without evidence of tumor pathology. Cohorts of INK4d-deficient mice treated neonatally with ionizing radiation or with the carcinogen dimethylbenzanthrene did not develop tumors at sites or rates that were significantly different from those seen in wild-type mice (27, 35). Together, these data failed to provide evidence that p19INK4d acts as a tumor suppressor.

Primary cells isolated from the INK4d-deficient animals, including mouse embryo fibroblasts (MEFs), bone marrow-derived macrophages and pro-B cells, thymic T cells, and splenic B cells, showed no cell cycle, proliferative, or differentiative anomalies (data not shown). For example, MEFs from INK4d-deficient embryos and their wild-type counterparts grew at the same rate, reached identical saturation densities, and entered senescence after a similar number of population doublings. Serum-starved INK4d-null MEFs exited the cell cycle normally and, when restimulated with mitogens, entered S phase at the same rate as their wild-type counterparts. The cells exhibited anchorage-dependent growth and were not sensitive to transformation by oncogenic Ha-Ras. Although p19INK4d is highly expressed in spleen and thymus (54), T and B lymphocytes derived from both spleen and thymus of these animals exhibited normal responses to lymphokines, as measured by their proliferation rates in culture, and displayed cell surface markers characteristic of their lineage. Pre- and pro-B cells cultured on IL-7-producing feeder layers (50) also exhibited characteristic lineage-specific markers without perturbation of differentiation. Bone marrow-derived macrophages from INK4d-deficient animals displayed the expected dependence on colony-stimulating factor-1 for proliferation and survival. Moreover, although IL-10 treatment of mouse bone marrow-derived macrophages leads to growth arrest associated with induction of p19INK4d, the macrophages explanted from the INK4d-deficient mice showed partial impairment in their ability to undergo arrest in response to IL-10 (30).

Testicular atrophy and increased apoptosis in INK4d-null animals. Visual examination at autopsy revealed obvious testicular atrophy in INK4d-deficient adult animals (Fig. 3A). Testes of males from all genotypes were weighed and measured between 7 and 14 weeks after mouse birth (Fig. 3B and Table 1). A statistically significant reduction in size (30 to 40%) was observed in the testes of INK4d-deficient animals (P < 0.01), whereas mice of all genotypes had comparable body weights. Histologic sections of testes from 3-month-old INK4d-deficient mice revealed that atrophy resulted from an overall reduction in size of the seminiferous tubules (Fig. 4C versus A and Fig. 4I versus H). Spermatozoa were nonetheless visualized in the lumina, consistent with the fact that fertility was not critically compromised in these animals.


View larger version (17K):
[in this window]
[in a new window]
  		FIG. 3.   Testicular atrophy in INK4d-deficient males. (A) Testes from 4-month-old wild-type (+/+) and INK4d-deficient (-/-) mice. (B) Comparison of the weights of wild-type (squares) and INK4d-deficient (triangles) testes at different ages of development. Additional data and statistical parameters are summarized in Table 1.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Testicular weight versus body weight in wild-type and INK4d-deficient micea

To analyze INK4d expression in testes, we performed in situ hybridization of tissue sections from adult wild-type mice using an antisense INK4d cDNA probe (Fig. 4B). Germ cell development begins at the periphery of the tubule where spermatogonia reside. These cells give rise to the progressively more differentiated spermatocytes and spermatids that populate the more superficial tubular layers, and ultimately yield mature spermatozoa that can normally be visualized in the tubular lumina (reference 38 and references therein). INK4d RNA staining was visualized throughout the tubular diameter, consistent with the idea that the gene is expressed in differentiating germ cells. No signal above background was observed in sections from INK4d-deficient testes (Fig. 4D). Since INK4d-deficient mice were generated by inserting a lacZ gene into exon 2 of the gene, beta -galactosidase expression under control of the INK4d promoter could reciprocally be observed in heterozygous and nullizygous mice by histochemical staining (Fig. 4F and G). As expected, staining of sections from INK4d-deficient testes revealed translumenal patterns of beta -galactosidase expression in tissues of both INK4d+/- and -/- mice, with heavier and more widespread staining observed in testes of animals that lacked both copies of the gene (Fig. 4G versus F). In testis sections from INK4d-deficient mice, we also observed many giant cells which appeared to correspond to apoptotic bodies that were not seen frequently in sections from wild-type mice (Fig. 4I [arrows] versus H). Consistent with this interpretation, we detected a significant increase in TUNEL-positive cells in testis sections from INK4d-deficient animals (Fig. 4K versus J). Therefore, INK4d plays a role in male germ cell development, but its loss is insufficient to completely compromise sperm cell production.


View larger version (96K):
[in this window]
[in a new window]
  		FIG. 4.   Deficient INK4d expression and apoptosis in testis. (Panels A to D) In situ hybridization, using an INK4d antisense riboprobe, was performed on testis sections from 6-week-old wild-type (A and B) and INK4d-deficient (C and D) mice. Panel A shows a toluidine blue-stained bright field of panel B, and panel C shows a bright field of panel D, all at equal magnification. (Panels E to G) Because the beta -geo cassette is encoded by the disrupted INK4d gene, tissues containing the mutant allele express beta -galactosidase, which was detected in tissues from hemizygous (F) and INK4d-null mice (G). Wild-type mice that lack the beta -geo cassette exhibit only background staining (E). All tissues were counterstained with neutral red dye. INK4d expression is heterogeneous throughout the tubules and is reduced by about 50% in heterozygous animals (cf. Fig. 2B). Under matched staining conditions, more intense and more uniform staining for beta -galactosidase is therefore observed in tubules from INK4d-deficient mice (G) than in testes from hemizygous animals (F). (Panels H to K) Sections from testes of wild-type (panels H and J) and INK4d-deficient mice (panels I and K) were photographed and reproduced at equal magnification and were stained with toluidine blue (H and I) or subjected to TUNEL assay (J and K). Increased apoptosis in INK4d-deficient animals correlated with testicular atrophy.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Deletion of INK4d alone does not compromise mouse development or lead to tumor formation. Among the four INK4 family members, INK4d is the most ubiquitously expressed. Yet, despite INK4d RNA expression throughout embryonic development and in virtually all mouse tissues examined (54), its targeted disruption did not affect fetal or adult development, and animals lacking p19INK4d function enjoyed a normal and otherwise uncomplicated life span. Moreover, despite the fact that neonatally irradiated and dimethylbenzanthrene-treated C57BL/6 mice develop lymphomas and skin tumors (17, 27, 35, 43), respectively, treated INK4d-deficient mice developed neither a greater number of tumors nor more aggressive tumors than wild-type littermates exposed to the same insults.

In general, the highest levels of p19INK4d protein expression occur in testis, spleen, thymus, and brain (54). Although INK4d loss partially compromised germ cell development in male mice, their sperm counts remained at sufficient levels to maintain their fertility, thereby producing no overt consequences. We saw no abnormalities in lymphoid T- or B-cell development, differentiation, or response to lymphokines, nor did we detect defects in the proliferation rate, cell cycle distribution, or mitogenic response of cultured MEFs or bone marrow-derived macrophages. The latter data are concordant with surveys from our own institution that failed to implicate genetic alterations of INK4d in pediatric hematologic malignancies involving myeloid or lymphoid cells (D. Reardon, J. Downing, C. J. Sherr, and M. F. Roussel, unpublished data).

The one place that INK4d expression has been relatively well characterized is in the central nervous system (55). INK4d is expressed during development of the brain from embryonic day 11.5 onward, primarily in postmitotic neurons. During development of the neocortex, asymmetric divisions give rise to differentiated neurons that exit the cell cycle and migrate to their final position in the brain (4, 6, 48), and it is only these postmitotic cells that express p19INK4d (55). INK4d expression is maintained into adulthood not only in postmitotic neurons of the cerebral cortex, but in neurons of the dentate gyrus, the pyramidal layer of the hippocampus, and in regions of the cerebellum, thalamus, and brainstem. Cyclin D1 levels also remain elevated in postmitotic neurons (10, 20), so that the persistence of p19INK4d might prevent reactivation of CDK4 and CDK6 in this context. This raised the possibility that INK4d loss might affect neuronal development or lead to brain tumors. Moreover, down regulation of p19INK4d in the dentate gyrus after kainic acid-induced seizures previously indicated that excitotoxic stress could modify INK4d expression in nondividing cells (55). Together, these data alluded to possible roles for INK4d in maintaining neurons in a quiescent state and/or modifying apoptotic responses to stress-induced signals, predictions that, at face value, were negated by the results reported here. The absence of brain tumors in the INK4d-deficient mouse after more than 2 years of follow up is consistent with our surveys of pediatric brain tumors, including medulloblastoma, ependymoma, and both low- and high-grade gliomas, in which we also failed to document any INK4d alterations (D. Reardon, J. Downing, C. J. Sherr, and M. F. Roussel, unpublished data).

INK4c is another INK4 family member expressed in the developing brain, but it resides exclusively in neuronal progenitors (55). Its inactivation also failed to cause neurologic defects, whether disrupted alone or in conjunction with the INK4d gene (M. Barbacid, F. Zindy, C. J. Sherr, and M. F. Roussel, unpublished data). On the other hand, analysis of expression of other CKIs revealed that INK4d and Kip1 were coexpressed in similar regions of the brain, particularly in the cerebral cortex (22, 55). In support of the idea that these two CKIs might play compensating roles in neocortical development, recent data from our laboratory indicate that codeletion of INK4d and Kip1 leads to ectopic neuronal proliferation in neonatal animals (53a).

Results of this type point to the need for generating mice that lack more than one CKI, in order to explore their potential for functional compensation in different tissues. There are already several precedents. Mice lacking Kip1 develop organomegaly and middle lobe pituitary hyperplasia (8, 19, 28), while those lacking INK4c develop middle lobe pituitary tumors late in life (9). However, animals that have lost both genes develop aggressive middle lobe pituitary tumors with a much earlier onset, suggesting that INK4c and Kip1 play overlapping roles in controlling pituitary development (9). Presumably, these results reflect modulation of Rb function, since Rb+/- animals also develop middle lobe pituitary tumors with accompanying loss of the wild-type Rb allele (13, 14). Cooperativity in regulating the cell cycle and controlling differentiation of the lens and placenta has been similarly documented in mice deleted for Kip1 and Kip2 (52), whereas muscle development is severely compromised in mice lacking Cip1 and Kip2, but not either gene alone (53).

INK4d-deficient mice display testicular atrophy associated with increased apoptosis. The single most remarkable finding in INK4d-deficient mice was marked testicular atrophy associated with increased apoptosis in germ cells, a site where p19INK4d is normally expressed (reference 54 and this work). Spermatogenesis provides a unique in vivo model for studying cell cycle exit and differentiation. Spermatogonia undergo mitosis, whereas spermatocytes undergo meiosis, yielding spermatids that differentiate into mature spermatozoa. CDK4 is expressed in spermatogonia and in early stage primary spermatocytes but does not contribute to later stages of germ cell development (18, 38). Patterns of INK4d expression imply that p19INK4d can be found in germ cells undergoing meiosis and during differentiation from spermatids to spermatozoa, so p19INK4d may help to prepare cells for meiosis by downregulating CDK4. Conversely, the marked increase in apoptosis in germ cells lacking INK4d suggests that cells that do not properly exit the mitotic cycle can be subsequently eliminated through activation of checkpoint controls that are triggered when S-phase entry occurs inappropriately. There are many cell systems in which apoptotic events depend upon proper Rb function (15, 49), consistent with the notion that p19INK4d exerts its known effects through the Rb pathway.

Spermatogenesis is only partially compromised in INK4d-deficient animals, again suggesting that other CKIs might also be involved in that process. We indeed found by in situ hybridization that INK4c was coexpressed with INK4d during spermatogenesis (data not shown), raising the possibility that INK4c might partially compensate for the lack of INK4d. Preliminary results from crosses between INK4d- and INK4c-deficient mice have revealed male sterility with virtual absence of spermatozoa in the lumina of seminiferous tubules. This indicates that INK4c and INK4d cooperate in male germ cell development and are both required for the production of mature spermatozoa. (F. Zindy, P. den Besten, P. Cohen, M. Barbacid, C. J. Sherr, and M. F. Roussel, unpublished data). Intriguingly, "knock-in" animals expressing a CDK4 mutant (R24C) that is resistant to INK4 inhibition show Leydig cell hyperplasia later in life (34), effects that we have also begun to observe in aging INK4c-INK4d double-null animals. To our knowledge, effects on male fertility represent the first pending example of functional cooperation between different INK4 family members during development.


    ACKNOWLEDGMENTS

We thank Paula Cohen (Albert Einstein University, New York, N.Y.) for help in the identification of testicular cells, Sandra d'Azzo for suggestions in initiating this project, members of the Roussel and Sherr laboratory for helpful discussions, Esther Latres and Maria Barbacid for communicating unpublished results, and John Cleveland for critical review of the manuscript. We also thank Anne-Marie Hamilton and Suzette Wingo for the characterization of B and T cells and Joseph Watson and Manjula Paruchuri for excellent technical assistance. We are indebted to Catherine Poquette, Xialong Luo, and James Boyette from the Department of Biostatistics at St. Jude Children's Research Hospital for statistical analysis.

This work was supported in part by NIH grant PO1 CA-71907, Cancer Core Grant CA-21765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. C.J.S. is an investigator of the Howard Hughes Medical Institute.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Tumor Cell Biology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105. Phone: (901) 495-3481. Fax: (901) 495-2381. E-mail: martine.roussel{at}stjude.org.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Alevizopoulos, K., J. Vlach, S. Hennecke, and B. Amati. 1997. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16:5322-5333[CrossRef][Medline].
2. Blain, S. W., E. Montalvo, and J. Massague. 1997. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272:25863-25872[Abstract/Free Full Text].
3. Brotherton, D. H., V. Dhanaraj, S. Wick, L. Brizuela, P. J. Domaille, E. Volyanik, X. Xu, E. Parisini, B. O. Smith, S. J. Archer, M. Serrano, S. L. Brenner, T. L. Blundell, and E. D. Laue. 1998. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature 395:244-250[CrossRef][Medline].
4. Caviness, V. S., Jr., T. Takahashi, and R. S. Nowakowski. 1995. Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci. 18:379-383[CrossRef][Medline].
5. Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21Cip1 and p27Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571-1583[CrossRef][Medline].
6. Chenn, A., and S. K. McConnell. 1995. Cleavage orientation and the asymmetric inheritance of Notch1 immunoreactivity in mammalian neurogenesis. Cell 82:631-642[CrossRef][Medline].
7. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262[Free Full Text].
8. Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L.-H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice. Cell 85:733-744[CrossRef][Medline].
9. Franklin, D. S., V. L. Godfrey, H. Lee, G. I. Kovalev, R. Schoonhoven, S. Chen-Kiang, L. Su, and Y. Xiong. 1998. CDK inhibitors p18INK4c and p27Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12:2899-2911[Abstract/Free Full Text].
10. Freeman, R. S., and E. M. Johnson, Jr. 1994. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355[CrossRef][Medline].
11. Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGFbeta -induced cell cycle arrest. Nature 371:257-261[CrossRef][Medline].
12. Hirai, H., M. F. Roussel, J. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681[Abstract].
13. Hu, N., A. Gutsmann, D. C. Herbert, A. Bradley, W.-H. Lee, and E. Y.-H. P. Lee. 1994. Heterozygous Rb-1D20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021-1027[Medline].
14. Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300[CrossRef][Medline].
15. Jacks, T., and R. A. Weinberg. 1996. Cell-cycle control and its watchman. Nature 381:643-644[CrossRef][Medline].
16. Jiang, H., H. S. Chou, and L. Zhu. 1998. Requirement of cyclin E-cdk2 inhibition in p16INK4a-mediated growth suppression. Mol. Cell. Biol. 18:5284-5290[Abstract/Free Full Text].
17. Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659[CrossRef][Medline].
18. Kang, M. J., M. K. Kim, A. Terhune, J. K. Park, Y. H. Kim, and G. Y. Koh. 1997. Cytoplasmic localization of cyclin D3 in seminiferous tubules during testicular development. Exp. Cell Res. 234:27-36[CrossRef][Medline].
19. Kiyokawa, H., R. D. Kineman, K. O. Manova-Todorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85:721-732[CrossRef][Medline].
20. Kranenburg, O., A. J. van der Eb, and A. Zantema. 1996. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15:46-54[Medline].
21. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862[Abstract/Free Full Text].
22. Lee, M.-H., M. Nikolic, C. A. Bapista, E. Lai, L.-H. Tsai, and J. Massagué. 1996. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc. Natl. Acad. Sci. USA 93:3259-3263[Abstract/Free Full Text].
23. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the Rb/E2F pathway. Genes Dev. 11:1479-1492[Abstract/Free Full Text].
24. McConnell, B. B., F. J. Gregory, F. J. Stott, E. Hara, and G. Peters. 1999. Induced expression of p16INK4a inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19:1981-1989[Abstract/Free Full Text].
25. Mitra, J., C. Y. Dai, K. Somasundaram, W. El-Deiry, K. Satamoorthy, M. Herlyn, and G. H. Enders. 1999. Induction of p21WAF1/Cip1 and inhibition of Cdk2 mediated by the tumor suppressor p16INK4a. Mol. Cell. Biol. 19:3916-3928[Abstract/Free Full Text].
26. Morse, L., D. Chen, D. Franklin, Y. Xiong, and S. Chen-Kiang. 1997. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18 (INK4c) and IL-6. Immunity 6:47-56[CrossRef][Medline].
27. Naito, M., and J. DiGiovanni. 1989. Genetic background and development of skin tumors, p. 187-212. In C. J. Conti, T. J. Slaga, and A. J. P. Klein-Szanto (ed.), Carcinogenesis, vol. III. Skin tumors: experimental and clinical aspects. Raven Press, New York, N.Y
28. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D. Y. Loh. 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720[CrossRef][Medline].
29. Oberdick, J., J. D. Wallace, A. Lewin, and R. J. Smeyne. 1994. Transgenic expression to monitor dynamic organization of neuronal development: use of Escherichia coli LacZ gene product, beta -galactosidase. Methods Neurosci. 5:54-62.
30. O'Farrell, A.-M., D. A. Parry, F. Zindy, M. F. Roussel, E. Lees, K. W. Moore, and A. L.-F. Mui. Inhibition of proliferation by IL-10 is mediated by Stat3-dependent induction of p19INK4d. J. Immunol., in press.
31. Parry, D. A., D. Mahony, K. Wills, and E. Lees. 1999. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19:1775-1783[Abstract/Free Full Text].
32. Pavletich, N. P. 1999. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287:821-828[CrossRef][Medline].
33. Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000[CrossRef][Medline].
34. Rane, S. G., P. Dubus, R. V. Mettus, E. J. Galbreath, G. Boden, E. P. Reddy, and M. Barbacid. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta -islet cell hyperplasia. Nat. Genet. 22:44-52[CrossRef][Medline].
35. Reiners, J. J., Jr., S. Nesnow, and T. J. Slaga. 1984. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis 5:301-307[Abstract/Free Full Text].
36. Reynisdóttir, I., and J. Massagué. 1997. The subcellular locations of p15INK4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492-503[Abstract/Free Full Text].
37. Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta . Genes Dev. 9:1831-1845[Abstract/Free Full Text].
38. Rhee, K., and D. J. Wolgemuth. 1995. Cdk family genes are expressed not only in dividing but also in terminally differentiated mouse germ cells, suggesting their possible function during both cell division and differentiation. Dev. Dyn. 204:406-420[Medline].
39. Roberts, J. M. 1999. Evolving ideas about cyclins. Cell 98:129-132[CrossRef][Medline].
39a. Roussel, M. F. 1999. The INK4 family of cell cycle inhibitors in cancer. Oncogene 18:5311-5317[CrossRef][Medline].
40. Ruas, M., and G. Peters. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. BBA Rev. Cancer 1378:F115-F177.
41. Russo, A. A., L. Tong, J.-O. Lee, P. D. Jeffrey, and N. P. Pavletich. 1998. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395:237-243[CrossRef][Medline].
42. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707[CrossRef][Medline].
43. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R. A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37[CrossRef][Medline].
44. Sherr, C., and J. M. Roberts. 1999. Positive and negative regulation by CDK inhibitors. Genes Dev. 13:1501-1512[Free Full Text].
45. Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059-1065[Medline].
46. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163[Free Full Text].
47. Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135-146[Abstract].
48. Takahashi, T., R. S. Nowakowshi, and V. S. Caviness. 1995. The cell cycle of the pseudostratified venticular epithelium of the embryonic murine cerebral wall. J. Neurosci. 15:6046-6057[Abstract].
49. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330[CrossRef][Medline].
50. Whitlock, C. A., and O. N. Witte. 1987. Long-term culture of murine bone marrow precursors of B lymphocytes. Methods Enzymol. 150:275-286[Medline].
51. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758[Abstract/Free Full Text].
52. Zhang, P., C. Wong, R. DePinho, J. W. Harper, and S. J. Elledge. 1998. Cooperation between the Cdk inhibitors p27KIP1 and p57KIP2 in the control of tissue growth and development. Genes Dev. 12:3162-3167[Abstract/Free Full Text].
53. Zhang, P., C. Wong, D. Liu, M. Finegold, J. W. Harper, and S. J. Elledge. 1999. p21Cip1 and p57Kip2 control muscle differentiation at the myogenin step. Genes Dev. 13:213-224[Abstract/Free Full Text].
53a. Zindy, F., J. J. Cunningham, C. J. Sherr, S. Jogal, R. J. Smeyne, and M. F. Roussel. Postnatal neuronal proliferation in mice lacking INK4a and KIP1 inhibitors of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA, in press.
54. Zindy, F., D. E. Quelle, M. F. Roussel, and C. J. Sherr. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203-211[CrossRef][Medline].
55. Zindy, F., H. Soares, K.-H. Herzog, J. Morgan, C. J. Sherr, and M. F. Roussel. 1997. Expression of INK4 inhibitors in cyclin D-dependent kinases during mouse brain development. Cell Growth Differ. 8:1139-1150[Abstract].

Molecular and Cellular Biology, January 2000, p. 372-378, Vol. 20, No. 1
0270-7306/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Eguchi, T., Itadani, H., Shimomura, T., Kawanishi, N., Hirai, H., Kotani, H. (2009). Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines. Molecular Cancer Therapeutics 8: 1460-1472 [Abstract] [Full Text]  
  • Lue, Y., Wang, C., Cui, Y., Wang, X., Sha, J., Zhou, Z., Xu, J., Wang, C., Sinha Hikim, A. P., Swerdloff, R. S. (2009). Levonorgestrel Enhances Spermatogenesis Suppression by Testosterone with Greater Alteration in Testicular Gene Expression in Men. Biol. Reprod. 80: 484-492 [Abstract] [Full Text]  
  • Ye, X., Skinner, M. K., Kennedy, G., Chun, J. (2008). Age-Dependent Loss of Sperm Production in Mice via Impaired Lysophosphatidic Acid Signaling. Biol. Reprod. 79: 328-336 [Abstract] [Full Text]  
  • Gilles, L., Guieze, R., Bluteau, D., Cordette-Lagarde, V., Lacout, C., Favier, R., Larbret, F., Debili, N., Vainchenker, W., Raslova, H. (2008). P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1. Blood 111: 4081-4091 [Abstract] [Full Text]  
  • Ramsey, M. R., Krishnamurthy, J., Pei, X.-H., Torrice, C., Lin, W., Carrasco, D. R., Ligon, K. L., Xiong, Y., Sharpless, N. E. (2007). Expression of p16Ink4a Compensates for p18Ink4c Loss in Cyclin-Dependent Kinase 4/6-Dependent Tumors and Tissues. Cancer Res. 67: 4732-4741 [Abstract] [Full Text]  
  • Laine, H., Doetzlhofer, A., Mantela, J., Ylikoski, J., Laiho, M., Roussel, M. F., Segil, N., Pirvola, U. (2007). p19Ink4d and p21Cip1 Collaborate to Maintain the Postmitotic State of Auditory Hair Cells, Their Codeletion Leading to DNA Damage and p53-Mediated Apoptosis. J. Neurosci. 27: 1434-1444 [Abstract] [Full Text]  
  • Cozar-Castellano, I., Haught, M., Stewart, A. F. (2006). The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo. Diabetes 55: 3271-3278 [Abstract] [Full Text]  
  • Fu, Y.-F., Zhu, Y.-N., Ni, J., Zhong, X.-G., Tang, W., Re, Y.-D., Shi, L.-P., Wan, J., Yang, Y.-F., Yuan, C., Nan, F.-J., Lawson, B. R., Zuo, J.-P. (2006). A Reversible S-Adenosyl-L-Homocysteine Hydrolase Inhibitor Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting T Cell Activation. J. Pharmacol. Exp. Ther. 319: 799-808 [Abstract] [Full Text]  
  • Chim, C S, Fung, T K, Wong, K F, Lau, J S, Law, M, Liang, R (2006). Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J. Clin. Pathol. 59: 921-926 [Abstract] [Full Text]  
  • Passegue, E., Wagers, A. J., Giuriato, S., Anderson, W. C., Weissman, I. L. (2005). Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. JEM 202: 1599-1611 [Abstract] [Full Text]  
  • Pei, X.-H., Bai, F., Tsutsui, T., Kiyokawa, H., Xiong, Y. (2004). Genetic Evidence for Functional Dependency of p18Ink4c on Cdk4. Mol. Cell. Biol. 24: 6653-6664 [Abstract] [Full Text]  
  • Atchison, F. W., Means, A. R. (2003). Spermatogonial Depletion in Adult Pin1-Deficient Mice. Biol. Reprod. 69: 1989-1997 [Abstract] [Full Text]  
  • Shen, L., Toyota, M., Kondo, Y., Obata, T., Daniel, S., Pierce, S., Imai, K., Kantarjian, H. M., Issa, J.-P. J., Garcia-Manero, G. (2003). Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood 101: 4131-4136 [Abstract] [Full Text]  
  • Bai, F., Pei, X.-H., Godfrey, V. L., Xiong, Y. (2003). Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis. Mol. Cell. Biol. 23: 1269-1277 [Abstract] [Full Text]  
  • Liou, Y.-C., Ryo, A., Huang, H.-K., Lu, P.-J., Bronson, R., Fujimori, F., Uchida, T., Hunter, T., Lu, K. P. (2002). Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 10.1073/pnas.032404099v1 [Abstract] [Full Text]  
  • Gadd, M., Pisc, C., Branda, J., Ionescu-Tiba, V., Nikolic, Z., Yang, C., Wang, T., Shackleford, G. M., Cardiff, R. D., Schmidt, E. V. (2001). Regulation of Cyclin D1 and p16INK4A Is Critical for Growth Arrest during Mammary Involution. Cancer Res. 61: 8811-8819 [Abstract] [Full Text]  
  • Rao, D. S., Chang, J. C., Kumar, P. D., Mizukami, I., Smithson, G. M., Bradley, S. V., Parlow, A. F., Ross, T. S. (2001). Huntingtin Interacting Protein 1 Is a Clathrin Coat Binding Protein Required for Differentiation of late Spermatogenic Progenitors. Mol. Cell. Biol. 21: 7796-7806 [Abstract] [Full Text]  
  • Wang, Z., Yu, R., Melmed, S. (2001). Mice Lacking Pituitary Tumor Transforming Gene Show Testicular and Splenic Hypoplasia, Thymic Hyperplasia, Thrombocytopenia, Aberrant Cell Cycle Progression, and Premature Centromere Division. Mol. Endocrinol. 15: 1870-1879 [Abstract] [Full Text]  
  • Sotillo, R., Garcia, J. F., Ortega, S., Martin, J., Dubus, P., Barbacid, M., Malumbres, M. (2001). Invasive melanoma in Cdk4-targeted mice. Proc. Natl. Acad. Sci. USA 10.1073/pnas.241338598v1 [Abstract] [Full Text]  
  • Kovalev, G. I., Franklin, D. S., Coffield, V. M., Xiong, Y., Su, L. (2001). An Important Role of CDK Inhibitor p18INK4c in Modulating Antigen Receptor-Mediated T Cell Proliferation. J. Immunol. 167: 3285-3292 [Abstract] [Full Text]  
  • Zindy, F., den Besten, W., Chen, B., Rehg, J. E., Latres, E., Barbacid, M., Pollard, J. W., Sherr, C. J., Cohen, P. E., Roussel, M. F. (2001). Control of Spermatogenesis in Mice by the Cyclin D-Dependent Kinase Inhibitors p18Ink4c and p19Ink4d. Mol. Cell. Biol. 21: 3244-3255 [Abstract] [Full Text]  
  • Inoue, K., Wen, R., Rehg, J. E., Adachi, M., Cleveland, J. L., Roussel, M. F., Sherr, C. J. (2000). Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev. 14: 1797-1809 [Abstract] [Full Text]  
  • Sherr, C. J. (2000). The Pezcoller Lecture: Cancer Cell Cycles Revisited. Cancer Res. 60: 3689-3695 [Abstract] [Full Text]  
  • Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., Pellicer, A. (2000). Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b. Mol. Cell. Biol. 20: 2915-2925 [Abstract] [Full Text]  
  • Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H. Jr., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., Lisanti, M. P. (2001). Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities. J. Biol. Chem. 276: 38121-38138 [Abstract] [Full Text]  
  • Liou, Y.-C., Ryo, A., Huang, H.-K., Lu, P.-J., Bronson, R., Fujimori, F., Uchida, T., Hunter, T., Lu, K. P. (2002). Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 99: 1335-1340 [Abstract] [Full Text]  
  • Sotillo, R., Garcia, J. F., Ortega, S., Martin, J., Dubus, P., Barbacid, M., Malumbres, M. (2001). Invasive melanoma in Cdk4-targeted mice. Proc. Natl. Acad. Sci. USA 98: 13312-13317 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zindy, F.
Right arrow Articles by Roussel, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zindy, F.
Right arrow Articles by Roussel, M. F.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»